Methylene blue

Generic Name
Methylene blue
Brand Names
Hyophen, Phosphasal, Provayblue, Proveblue, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Urogesic Blue Reformulated Apr 2012, Ustell, Utira, Lumeblue (previously known as Methylthioninium chloride Cosmo), Methylthioninium chloride Proveblue
Drug Type
Small Molecule
Chemical Formula
C16H18ClN3S
CAS Number
61-73-4
Unique Ingredient Identifier
8NAP7826UB
Background

Methylene blue is an oxidation-reduction agent. The intravenous form of methylene blue is approved by the FDA for the treatment of pediatric and adult patients with acquired methemoglobinemia. Historically, it has been widely used in Africa to treat malaria, but now it disappeared when chloroquine (CQ) and other drugs entered the market. Its use as an urinar...

Indication

Indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
...

Associated Conditions
Cystitis, Methemoglobinemia, Nephritis, Urethritis, Urinary tract inflammation
Associated Therapies
Diuresis
Clinical Trials
Related News

Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome

First Posted Date
2005-09-12
Last Posted Date
2015-10-06
Lead Sponsor
Northern State Medical University
Target Recruit Count
28
Registration Number
NCT00159510
Locations
🇷🇺

University Hospital #1, Arkhangelsk, Russia, Russian Federation

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

First Posted Date
2003-10-07
Last Posted Date
2017-11-06
Lead Sponsor
Gynecologic Oncology Group
Target Recruit Count
102
Registration Number
NCT00070317
Locations
🇺🇸

Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy